2016
$105M
from 26 investors over 26 rounds
Senti Biosciences raised $51M on June 9, 2022
Investors: Parker Institute for Cancer Immunotherapy, T. Rowe Price, Leaps by Bayer, The Invus Group, Pear VC and 8VC
Senti Biosciences raised $5.2M on May 24, 2022
Investors: Leaps by Bayer
Senti Biosciences raised $1.9M on September 28, 2021
Investors: National Cancer Institute
Senti Biosciences raised undisclosed on May 14, 2021
Investors: Pear VC
Senti Biosciences raised $105M on January 6, 2021
Investors: Smilegate Investment, 经纬创投(北京)投资管理顾问有限公司, Ridgeback Capital Management LLC, Sand Hill Angels, Noveus Capital, Menlo Ventures and Pear VC
Senti Biosciences raised undisclosed on August 20, 2020
Investors: Bossa Nova Investimentos
Senti Biosciences raised undisclosed on January 16, 2019
Investors: Pear VC
Senti Biosciences raised $53M on February 27, 2018
Investors: Omega Funds, Evolution VC Partners, Lifeforce Capital, Lux Capital, Pear VC, Menlo Ventures and Allen & Company LLC.
Senti Biosciences raised undisclosed on September 22, 2016
Investors: Pear VC